Video

Q&A With Robert Eckel From the University of Colorado: Major Medical Organizations Largely Agree on New Cholesterol Guidelines

Author(s):

With new medications and therapies being developed for a variety of conditions, a consistent message from the medical community can help move treatment forward.

With new medications and therapies being developed for a variety of conditions, a consistent message from the medical community can help move treatment forward.

Robert Eckel, MD, from the University of Colorado Anschutz Medical Campus discussed new guidelines that have been adopted by the American Heart Association, the American College of Cardiology, and the American Diabetes Assocation during the latter's 75th Annual Scientific Sessions in Boston. While there are only some minor disagreements, Eckel said one major difference is whether a risk management program could help patients monitor their health.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.